BioCentury | Dec 8, 2017
Company News

Astellas acquires build-to-buy Mitobridge

...to improve or regenerate mitochondrial function in neuromuscular, cardiovascular and metabolic disorders. Astellas, MPM and Longwood Founders Fund...
BioCentury | Dec 2, 2017
Company News

Astellas acquires build-to-buy Mitobridge

...to improve or regenerate mitochondrial function in neuromuscular, cardiovascular and metabolic disorders. Astellas, MPM and Longwood Founders Fund...
BioCentury | May 19, 2014
Emerging Company Profile

Mitokyne: Energy pipeline

...Astellas Pharma Inc. Number of employees: 7 Funds raised: $45 million Investors: Astellas; MPM Capital; Longwood Founders Fund...
BioCentury | Oct 14, 2013
Company News

Mitokyne board of directors update

...Mitokyne Inc. , Boston, Mass. Business: Neurology, Endocrine/Metabolic Appointed: Rich Aldrich, partner at Longwood Founders Fund; Ansbert Gadicke...
BioCentury | Oct 14, 2013
Financial News

Mitokyne completes venture financing

...completed: 10/7/13 Type: Venture financing Raised: $45 million Investors: Astellas Pharma Inc. ; MPM Capital; Longwood Founders Fund WIR...
BioCentury | Oct 7, 2013
Top Story

Mitokyne raises $45M, partners with Astellas

...including Astellas' equity investment in Mitokyne, it could be over $500 million. MPM Capital and Longwood Founders Fund...
BioCentury | Feb 6, 2012
Finance

Westphal's window

...high risk of metastasis. Verastem raised $68 million in three venture rounds. Investors included Westphal's Longwood Founders Fund...
BioCentury | Nov 7, 2011
Financial News

Verastem completes venture financing

...completed: 11/1/11 Type: Venture financing Raised: $21 million Investors: Advanced Technology Ventures; Bessemer Venture Partners; Longwood Founders Fund...
BioCentury | Nov 7, 2011
Finance

Verastem very aggressive

...operating loss of $7.7 million in the first nine months of 2011. Investors include Westphal's Longwood Founders Fund...
BioCentury | Nov 4, 2011
Financial News

Westphal's Verastem files for IPO

...and was acquired by GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) in 2008. Westphal is the founder of Longwood Founders Fund...
Items per page:
1 - 10 of 26
BioCentury | Dec 8, 2017
Company News

Astellas acquires build-to-buy Mitobridge

...to improve or regenerate mitochondrial function in neuromuscular, cardiovascular and metabolic disorders. Astellas, MPM and Longwood Founders Fund...
BioCentury | Dec 2, 2017
Company News

Astellas acquires build-to-buy Mitobridge

...to improve or regenerate mitochondrial function in neuromuscular, cardiovascular and metabolic disorders. Astellas, MPM and Longwood Founders Fund...
BioCentury | May 19, 2014
Emerging Company Profile

Mitokyne: Energy pipeline

...Astellas Pharma Inc. Number of employees: 7 Funds raised: $45 million Investors: Astellas; MPM Capital; Longwood Founders Fund...
BioCentury | Oct 14, 2013
Company News

Mitokyne board of directors update

...Mitokyne Inc. , Boston, Mass. Business: Neurology, Endocrine/Metabolic Appointed: Rich Aldrich, partner at Longwood Founders Fund; Ansbert Gadicke...
BioCentury | Oct 14, 2013
Financial News

Mitokyne completes venture financing

...completed: 10/7/13 Type: Venture financing Raised: $45 million Investors: Astellas Pharma Inc. ; MPM Capital; Longwood Founders Fund WIR...
BioCentury | Oct 7, 2013
Top Story

Mitokyne raises $45M, partners with Astellas

...including Astellas' equity investment in Mitokyne, it could be over $500 million. MPM Capital and Longwood Founders Fund...
BioCentury | Feb 6, 2012
Finance

Westphal's window

...high risk of metastasis. Verastem raised $68 million in three venture rounds. Investors included Westphal's Longwood Founders Fund...
BioCentury | Nov 7, 2011
Financial News

Verastem completes venture financing

...completed: 11/1/11 Type: Venture financing Raised: $21 million Investors: Advanced Technology Ventures; Bessemer Venture Partners; Longwood Founders Fund...
BioCentury | Nov 7, 2011
Finance

Verastem very aggressive

...operating loss of $7.7 million in the first nine months of 2011. Investors include Westphal's Longwood Founders Fund...
BioCentury | Nov 4, 2011
Financial News

Westphal's Verastem files for IPO

...and was acquired by GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) in 2008. Westphal is the founder of Longwood Founders Fund...
Items per page:
1 - 10 of 26